EFSA Publishes Reasoned Opinions for Azoxystrobin
date:Dec 11, 2013
as well as the import tolerances andEuropean authorisations reported by Member States (incl. the supporting residues data).

Based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out. Although no apparent risk to consumers was identified, some information required by the regulatory framework was found to be missing. Hence, the consumer risk assessment is considered indicative only and some MRL proposals derived by EFSA still requir
2/3 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/21 05:04